Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $95.4B |
| FY2017, ended Dec 31, 2017 | $174B |
| FY2018, ended Dec 31, 2018 | $182B |
| FY2019, ended Dec 31, 2019 | $183B |
| FY2020, ended Dec 31, 2020 | $125B |
| FY2021, ended Dec 31, 2021 | $117B |
| FY2022, ended Dec 31, 2022 | $114B |
| FY2023, ended Dec 31, 2023 | $159B |
| FY2024, ended Dec 31, 2024 | $133B |
| FY2025, ended Dec 31, 2025 | $171B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $147B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $93.5B |
| FY2017, ended Dec 31, 2017 | $94.0B |
| FY2018, ended Dec 31, 2018 | $101B |
| FY2019, ended Dec 31, 2019 | $76.6B |
| FY2020, ended Dec 31, 2020 | $58.2B |
| FY2021, ended Dec 31, 2021 | $62.3B |
| FY2022, ended Dec 31, 2022 | $66.6B |
| FY2023, ended Dec 31, 2023 | $77.8B |
| FY2024, ended Dec 31, 2024 | $66.5B |
| FY2025, ended Dec 31, 2025 | $89.5B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $94.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.03B | $7.88B |
| FY2017, ended Dec 31, 2017 | $8.46B | $11.6B |
| FY2018, ended Dec 31, 2018 | $10.5B | $13.6B |
| FY2019, ended Dec 31, 2019 | −$636M | −$4.28B |
| FY2020, ended Dec 31, 2020 | −$11.9B | −$19.7B |
| FY2021, ended Dec 31, 2021 | −$4.20B | −$4.40B |
| FY2022, ended Dec 31, 2022 | −$4.93B | $2.29B |
| FY2023, ended Dec 31, 2023 | −$2.22B | $4.43B |
| FY2024, ended Dec 31, 2024 | −$11.8B | −$14.3B |
| FY2025, ended Dec 31, 2025 | $2.23B | −$1.88B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $7.66B | $16.0M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.80B |
| FY2017, ended Dec 31, 2017 | $8.81B |
| FY2018, ended Dec 31, 2018 | $7.64B |
| FY2019, ended Dec 31, 2019 | $9.48B |
| FY2020, ended Dec 31, 2020 | $7.75B |
| FY2021, ended Dec 31, 2021 | $8.05B |
| FY2022, ended Dec 31, 2022 | $14.6B |
| FY2023, ended Dec 31, 2023 | $12.7B |
| FY2024, ended Dec 31, 2024 | $13.8B |
| FY2025, ended Dec 31, 2025 | $10.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $9.50B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $9.95B |
| FY2017, ended Dec 31, 2017 | $11.1B |
| FY2018, ended Dec 31, 2018 | $13.8B |
| FY2019, ended Dec 31, 2019 | $27.1B |
| FY2020, ended Dec 31, 2020 | $63.4B |
| FY2021, ended Dec 31, 2021 | $57.9B |
| FY2022, ended Dec 31, 2022 | $56.8B |
| FY2023, ended Dec 31, 2023 | $52.1B |
| FY2024, ended Dec 31, 2024 | $53.6B |
| FY2025, ended Dec 31, 2025 | $53.8B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $45.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 29.4% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 612M |
| FY2017, ended Dec 31, 2017 | 588M |
| FY2018, ended Dec 31, 2018 | 565M |
| FY2019, ended Dec 31, 2019 | 563M |
| FY2020, ended Dec 31, 2020 | 583M |
| FY2021, ended Dec 31, 2021 | 583M |
| FY2022, ended Dec 31, 2022 | 598M |
| FY2023, ended Dec 31, 2023 | 610M |
| FY2024, ended Dec 31, 2024 | 750M |
| FY2025, ended Dec 31, 2025 | 785M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 792M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $7.00B | $190M | — | — |
| FY2017, ended Dec 31, 2017 | $9.24B | $202M | — | — |
| FY2018, ended Dec 31, 2018 | $9.00B | $202M | — | — |
| FY2019, ended Dec 31, 2019 | $2.65B | $212M | — | — |
| FY2020, ended Dec 31, 2020 | — | $250M | — | — |
| FY2021, ended Dec 31, 2021 | — | $833M | — | — |
| FY2022, ended Dec 31, 2022 | — | $725M | — | — |
| FY2023, ended Dec 31, 2023 | — | $690M | — | — |
| FY2024, ended Dec 31, 2024 | — | $407M | $18.2B | — |
| FY2025, ended Dec 31, 2025 | — | $426M | — | $4.70B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — | $444M | — | — |
Valuation
At current price- Market Cap
- $133B
- P/E
- 17.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.4×
- Price / Book
- 20.4×
- EV / EBITDA
- 14.1×
Growth
Trailing 12 months- Revenue (TTM)
- $94.9B
- Revenue Growth YoY
- 17.5%
- Revenue CAGR 3Y
- 10.3%
- Revenue CAGR 5Y
- 9.0%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 9.4%
- Operating Margin
- 10.3%
- Net Margin
- 8.1%
- FCF Margin
- 0.0%
- Return on Equity
- 117%
Earnings
Trailing 12 months- Net Income
- $7.66B
- EPS (diluted)
- $9.69
- EBITDA
- $12.0B
- Operating Income
- $9.73B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $9.50B
- Total Debt
- $45.6B
- Net Debt
- $36.1B
- Total Assets
- $171B
- Total Liabilities
- $164B
- Shareholders' Equity
- $6.55B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.01B
- Capital Expenditure
- $4.00B
- Free Cash Flow
- $16.0M
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.26
Every ratio is calculated from the company’s reported figures.